Foods

Chr. Hansen’s 2025 strategy – reinvestment focus

  • Sectors : Foods
  • Companies : Givaudan | Symrise

Ratings

Ratings and price correct at time of issue

Company Rating Date Previous Rating Date Closing Price
Givaudan OUTPERFORM 24/03/20 Neutral 21/06/12 378800chf
Symrise OUTPERFORM 24/03/20 Neutral 15/01/19 11530c

DAVY VIEW

Reinvestment is the key theme of Chr. Hansen’s new medium-term strategy – focused on its core microbial and probiotics platform, claimed to be the most prominent in the world. While the top-line growth target of mid to high-single-digits is as expected, margin expectations reflect reinvestment ambitions. Management has placed a heavy emphasis on opportunities in plant-based and the growing probiotics market in Asia, reinforced by recent acquisitions. Immunity-related products and nutrition platforms have been clear beneficiaries of the crisis – trading on 45x FY2 EPS, the market is betting on the growth sustainability of such.

Download full report with analyst certification and important disclosures

Aug 26 2020, 07:45 IST/BST

Download